Palomar Holdings, Inc. (PLMR) 10-Year Financial Performance & Capital Metrics

PLMR • • Insurance & Managed Care

Financial ServicesProperty & Casualty InsurancePersonal Lines InsuranceSpecialty Personal Lines

AboutPalomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.Show more

Revenue $554M +47.3%
Combined Ratio 72.7% +0.4%
Net Income $118M +48.4%
Return on Equity 19.59% +5.9%
Medical Cost Ratio 51.35% +7.0%
Operating Margin 27.3% -1.0%
Net Margin 21.23% +0.8%
ROA 5.92% +12.7%
Equity / Assets 32.23% +16.8%
Book Value per Share 27.80 +49.4%
Tangible BV/Share 27.30 +50.6%
Debt/Equity -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 72.7% combined ratio
✓Strong 5Y profit CAGR of 61.7%
✓Low loss ratio of 51.4%
✓Good 3Y average ROE of 17.2%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y37.35%

3Y30.75%

TTM54.08%

Profit (Net Income) CAGR

10Y-

5Y61.74%

3Y36.88%

TTM62.09%

EPS CAGR

10Y-

5Y55.67%

3Y36.54%

TTM52.26%

ROCE

10Y Avg5.91%

5Y Avg5.72%

3Y Avg6.85%

Latest7.62%

Peer Comparison

Specialty Personal Lines

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HGTYHagerty, Inc.	1.28B	12.77	127.70	17.77%	3.18%	6.06%	12.13%	0.28
PLMRPalomar Holdings, Inc.	3.46B	130.41	29.11	47.33%	22.66%	20.03%	7.55%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	42.7M	59.47M	72.97M	113.3M	168.46M	247.79M	327.09M	375.93M	553.86M
Revenue Growth %	-	0.39%	0.23%	0.55%	0.49%	0.47%	0.32%	0.15%	0.47%
Medical Costs & Claims+	24.63M	37.65M	34.5M	42.85M	128.16M	136.89M	189.44M	180.34M	284.42M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-
Gross Profit+	18.06M	21.82M	38.47M	70.44M	40.31M	110.9M	137.64M	195.59M	269.45M
Gross Margin %	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	0.21%	0.76%	0.83%	-0.43%	1.75%	0.24%	0.42%	0.38%
Operating Expenses+	11.79M	16.89M	20.26M	52.37M	34.08M	53.76M	70.09M	91.95M	118.25M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	88K	160K	212K	216K	1.34M	3.54M	4.12M	4.5M	5.11M
Combined Ratio %	-	-	-	-	-	-	-	-	-
Operating Income+	6.28M	4.93M	18.21M	18.08M	6.22M	57.14M	67.55M	103.64M	151.2M
Operating Margin %	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-	-0.21%	2.7%	-0.01%	-0.66%	8.18%	0.18%	0.53%	0.46%
EBITDA+	6.37M	5.09M	18.43M	18.29M	7.56M	60.68M	71.67M	108.14M	156.3M
EBITDA Margin %	-	-	-	-	-	-	-	-	-
Interest Expense	1.63M	1.75M	2.3M	1.07M	0	40K	873K	3.77M	1.14M
Non-Operating Income	-1.63M	-1.75M	-2.3M	-1.07M	0	-40K	-873K	-3.77M	-1.14M
Pretax Income+	6.28M	4.93M	18.21M	18.08M	6.22M	57.14M	67.55M	103.64M	151.2M
Pretax Margin %	-	-	-	-	-	-	-	-	-
Income Tax+	-337K	1.15M	-6K	7.46M	-34K	11.29M	15.38M	24.44M	33.62M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-
Net Income+	6.61M	3.78M	18.22M	10.62M	6.26M	45.85M	52.17M	79.2M	117.57M
Net Margin %	-	-	-	-	-	-	-	-	-
Net Income Growth %	-	-0.43%	3.82%	-0.42%	-0.41%	6.33%	0.14%	0.52%	0.48%
EPS (Diluted)+	0.29	0.17	0.81	0.49	0.24	1.76	2.02	3.13	4.48
EPS Growth %	-	-0.41%	3.76%	-0.4%	-0.51%	6.33%	0.15%	0.55%	0.43%
EPS (Basic)	0.29	0.17	0.81	0.49	0.25	1.80	2.07	3.19	4.61
Diluted Shares Outstanding	22.63M	22.63M	22.63M	21.83M	25.6M	26.11M	25.8M	25.33M	26.22M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	145.13M	188.35M	231.13M	395.46M	729.09M	925.73M	1.31B	1.71B	2.26B
Asset Growth %	-	0.3%	0.23%	0.71%	0.84%	0.27%	0.41%	0.31%	0.32%
Total Investment Assets+	0	125.5M	147.39M	456.63M	820.3M	465.94M	553.64M	689.58M	987.72M
Long-Term Investments	0	125.5M	147.39M	239.48M	422.31M	465.94M	553.64M	689.58M	981.85M
Short-Term Investments	0	101.91M	122.22M	217.15M	397.99M	432.68M	515.06M	643.8M	470.43M
Total Current Assets+	9.76M	142.66M	164.94M	303.76M	585.1M	0	0	0	0
Cash & Equivalents	9.76M	10.78M	9.53M	33.12M	33.54M	50.28M	68.11M	51.55M	80.44M
Receivables	0	1000K	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	8.4M	31.91M	54.17M	0	-786.61M	-1.14B	-1.5B	-1.53B
Goodwill & Intangibles+	11.4M	744K	744K	744K	11.51M	9.5M	8.26M	12.31M	13.24M
Goodwill	0	0	0	0	0	0	0	3.75M	3.75M
Intangible Assets	11.4M	744K	744K	744K	11.51M	9.5M	8.26M	8.56M	9.49M
PP&E (Net)	920K	827K	947K	845K	739K	527K	603K	373K	429K
Other Assets	123.06M	-127.07M	-149.08M	-4.58M	-8.6M	-475.97M	-562.5M	-702.26M	-995.52M
Total Liabilities	16.97M	109.94M	139.96M	176.91M	365.38M	531.57M	921.7M	1.24B	1.53B
Total Debt+	16.97M	17.09M	19.08M	0	0	0	36.4M	52.6M	0
Net Debt	7.22M	6.31M	9.55M	-33.12M	-33.54M	-50.28M	-31.71M	1.05M	-80.44M
Long-Term Debt	16.97M	17.09M	19.08M	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	36.4M	52.6M	0
Total Current Liabilities+	0	11.57M	24.97M	1.12M	42.96M	0	0	0	0
Accounts Payable	0	11.57M	19.85M	24.94M	42.96M	58.74M	171.89M	224.12M	260.25M
Deferred Revenue	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	-11.58M	-19.85M	-24.93M	0	-58.74M	-208.29M	-283.97M	-260.25M
Deferred Taxes	0	0	0	1000K	1000K	1000K	0	0	0
Other Liabilities	0	0	0	0	0	-3.91M	0	0	0
Total Equity+	73.11M	78.41M	91.17M	218.56M	363.71M	394.17M	384.75M	471.25M	729.03M
Equity Growth %	-	0.07%	0.16%	1.4%	0.66%	0.08%	-0.02%	0.22%	0.55%
Shareholders Equity	73.11M	78.41M	91.17M	218.56M	363.71M	394.17M	384.75M	471.25M	729.03M
Minority Interest	0	0	0	0	0	0	0	0	0
Retained Earnings	3.59M	6.92M	275K	33.86M	39.96M	69.95M	87.71M	144.64M	262.22M
Common Stock	0	2K	2K	2K	3K	3K	3K	3K	3K
Accumulated OCI	1.02M	2.99M	-563K	4.69M	13.25M	5.31M	-36.52M	-23.99M	-26.84M
Return on Equity (ROE)	0.09%	0.05%	0.21%	0.07%	0.02%	0.12%	0.13%	0.19%	0.2%
Return on Assets (ROA)	0.05%	0.02%	0.09%	0.03%	0.01%	0.06%	0.05%	0.05%	0.06%
Equity / Assets	-	-	-	-	-	-	-	-	-
Debt / Equity	0.23x	0.22x	0.21x	-	-	-	0.09x	0.11x	-
Book Value per Share	3.23	3.47	4.03	10.01	14.21	15.10	14.92	18.61	27.80
Tangible BV per Share	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	15.82M	20.25M	22.81M	41.7M	53.55M	87.81M	169.58M	116.11M	261.16M
Operating CF Growth %	-	0.28%	0.13%	0.83%	0.28%	0.64%	0.93%	-0.32%	1.25%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-
Net Income	6.61M	3.78M	18.22M	10.62M	6.26M	45.85M	52.17M	79.2M	117.57M
Depreciation & Amortization	88K	160K	212K	216K	1.34M	3.54M	4.12M	4.5M	5.11M
Stock-Based Compensation	0	0	0	24.1M	2.17M	5.58M	11.62M	14.91M	16.68M
Deferred Taxes	-337K	1.13M	0	646K	1.09M	641K	-3.52M	-2.83M	2.11M
Other Non-Cash Items	581K	473K	3.49M	-3.09M	-274K	1.15M	9.37M	-2.95M	-5.51M
Working Capital Changes	8.88M	14.7M	884K	9.2M	42.97M	31.05M	95.82M	23.27M	125.2M
Cash from Investing+	-11.53M	-19.13M	-25.36M	-80.57M	-181.44M	-58.19M	-156.81M	-128.48M	-306.24M
Capital Expenditures	-898K	-68K	-332K	-2.93M	-4.07M	-18K	-313K	-15K	-243K
Acquisitions	4K	0	0	2.81M	-7.07M	-11K	-15K	-8.53M	0
Purchase of Investments	-40.1M	-54.21M	-136.46M	-270.44M	-341.95M	-216.57M	-392.63M	-234.72M	-607.1M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Other Investing	4K	-250K	250K	1.02M	1.42M	-3.34M	-6.57M	-5.79M	301.1M
Cash from Financing+	0	0	1.55M	62.29M	128.33M	-13.04M	5.02M	-3.94M	73.77M
Dividends Paid	0	0	0	-5.12M	0	0	0	0	0
Share Repurchases	0	0	0	0	0	-15.85M	-34.41M	-22.27M	0
Stock Issued	0	0	0	87.41M	125.55M	0	0	0	123.62M
Debt Issuance (Net)	0	0	1000K	-1000K	0	0	1000K	1000K	1000K
Other Financing	0	0	0	0	2.78M	2.81M	3.03M	2.13M	-112.97M
Net Change in Cash+	4.29M	1.12M	-1.01M	23.43M	437K	16.59M	17.79M	-16.31M	28.69M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0
Cash at Beginning	5.52M	9.81M	10.93M	9.92M	33.35M	33.79M	50.37M	68.16M	51.85M
Cash at End	9.81M	10.93M	9.92M	33.35M	33.79M	50.37M	68.16M	51.85M	80.54M
Free Cash Flow+	14.93M	20.18M	22.48M	38.77M	49.48M	82.96M	163.65M	109.35M	260.91M
FCF Growth %	-	0.35%	0.11%	0.73%	0.28%	0.68%	0.97%	-0.33%	1.39%
FCF Margin %	-	-	-	-	-	-	-	-	-
FCF per Share	0.66	0.89	0.99	1.78	1.93	3.18	6.34	4.32	9.95

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	85.3%	91.71%	75.04%	84.04%	96.31%	76.94%	79.35%	72.43%	72.7%
Medical Cost Ratio	57.69%	63.31%	47.28%	37.82%	76.07%	55.24%	57.92%	47.97%	51.35%
Return on Equity (ROE)	9.05%	4.99%	21.49%	6.86%	2.15%	12.1%	13.4%	18.5%	19.59%
Return on Assets (ROA)	4.56%	2.27%	8.69%	3.39%	1.11%	5.54%	4.67%	5.25%	5.92%
Equity / Assets	50.37%	41.63%	39.45%	55.27%	49.89%	42.58%	29.45%	27.59%	32.23%
Book Value / Share	3.23	3.47	4.03	10.01	14.21	15.1	14.92	18.61	27.8
Debt / Equity	0.23x	0.22x	0.21x	-	-	-	0.09x	0.11x	-
Revenue Growth	-	39.28%	22.71%	55.26%	48.69%	47.09%	32%	14.93%	47.33%

Frequently Asked Questions

Valuation & Price

Palomar Holdings, Inc. (PLMR) has a price-to-earnings (P/E) ratio of 29.1x. This suggests investors expect higher future growth.

Growth & Financials

Palomar Holdings, Inc. (PLMR) grew revenue by 47.3% over the past year. This is strong growth.

Yes, Palomar Holdings, Inc. (PLMR) is profitable, generating $175.9M in net income for fiscal year 2024 (21.2% net margin).

Dividend & Returns

Palomar Holdings, Inc. (PLMR) has a return on equity (ROE) of 19.6%. This is reasonable for most industries.

Industry Metrics

Palomar Holdings, Inc. (PLMR) has a combined ratio of 72.7%. A ratio below 100% indicates underwriting profitability.

← Back to Screener

US Stock Screener

...

Palomar Holdings, Inc. (PLMR) 10-Year Financial Performance & Capital Metrics

PLMR • • Insurance & Managed Care

Financial ServicesProperty & Casualty InsurancePersonal Lines InsuranceSpecialty Personal Lines

Revenue $554M +47.3%
Combined Ratio 72.7% +0.4%
Net Income $118M +48.4%
Return on Equity 19.59% +5.9%
Medical Cost Ratio 51.35% +7.0%
Operating Margin 27.3% -1.0%
Net Margin 21.23% +0.8%
ROA 5.92% +12.7%
Equity / Assets 32.23% +16.8%
Book Value per Share 27.80 +49.4%
Tangible BV/Share 27.30 +50.6%
Debt/Equity -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 72.7% combined ratio
✓Strong 5Y profit CAGR of 61.7%
✓Low loss ratio of 51.4%
✓Good 3Y average ROE of 17.2%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y37.35%

3Y30.75%

TTM54.08%

Profit (Net Income) CAGR

10Y-

5Y61.74%

3Y36.88%

TTM62.09%

EPS CAGR

10Y-

5Y55.67%

3Y36.54%

TTM52.26%

ROCE

10Y Avg5.91%

5Y Avg5.72%

3Y Avg6.85%

Latest7.62%

Peer Comparison

Specialty Personal Lines

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HGTYHagerty, Inc.	1.28B	12.77	127.70	17.77%	3.18%	6.06%	12.13%	0.28
PLMRPalomar Holdings, Inc.	3.46B	130.41	29.11	47.33%	22.66%	20.03%	7.55%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	42.7M	59.47M	72.97M	113.3M	168.46M	247.79M	327.09M	375.93M	553.86M
Revenue Growth %	-	0.39%	0.23%	0.55%	0.49%	0.47%	0.32%	0.15%	0.47%
Medical Costs & Claims+	24.63M	37.65M	34.5M	42.85M	128.16M	136.89M	189.44M	180.34M	284.42M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-
Gross Profit+	18.06M	21.82M	38.47M	70.44M	40.31M	110.9M	137.64M	195.59M	269.45M
Gross Margin %	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	0.21%	0.76%	0.83%	-0.43%	1.75%	0.24%	0.42%	0.38%
Operating Expenses+	11.79M	16.89M	20.26M	52.37M	34.08M	53.76M	70.09M	91.95M	118.25M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	88K	160K	212K	216K	1.34M	3.54M	4.12M	4.5M	5.11M
Combined Ratio %	-	-	-	-	-	-	-	-	-
Operating Income+	6.28M	4.93M	18.21M	18.08M	6.22M	57.14M	67.55M	103.64M	151.2M
Operating Margin %	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-	-0.21%	2.7%	-0.01%	-0.66%	8.18%	0.18%	0.53%	0.46%
EBITDA+	6.37M	5.09M	18.43M	18.29M	7.56M	60.68M	71.67M	108.14M	156.3M
EBITDA Margin %	-	-	-	-	-	-	-	-	-
Interest Expense	1.63M	1.75M	2.3M	1.07M	0	40K	873K	3.77M	1.14M
Non-Operating Income	-1.63M	-1.75M	-2.3M	-1.07M	0	-40K	-873K	-3.77M	-1.14M
Pretax Income+	6.28M	4.93M	18.21M	18.08M	6.22M	57.14M	67.55M	103.64M	151.2M
Pretax Margin %	-	-	-	-	-	-	-	-	-
Income Tax+	-337K	1.15M	-6K	7.46M	-34K	11.29M	15.38M	24.44M	33.62M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-
Net Income+	6.61M	3.78M	18.22M	10.62M	6.26M	45.85M	52.17M	79.2M	117.57M
Net Margin %	-	-	-	-	-	-	-	-	-
Net Income Growth %	-	-0.43%	3.82%	-0.42%	-0.41%	6.33%	0.14%	0.52%	0.48%
EPS (Diluted)+	0.29	0.17	0.81	0.49	0.24	1.76	2.02	3.13	4.48
EPS Growth %	-	-0.41%	3.76%	-0.4%	-0.51%	6.33%	0.15%	0.55%	0.43%
EPS (Basic)	0.29	0.17	0.81	0.49	0.25	1.80	2.07	3.19	4.61
Diluted Shares Outstanding	22.63M	22.63M	22.63M	21.83M	25.6M	26.11M	25.8M	25.33M	26.22M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	145.13M	188.35M	231.13M	395.46M	729.09M	925.73M	1.31B	1.71B	2.26B
Asset Growth %	-	0.3%	0.23%	0.71%	0.84%	0.27%	0.41%	0.31%	0.32%
Total Investment Assets+	0	125.5M	147.39M	456.63M	820.3M	465.94M	553.64M	689.58M	987.72M
Long-Term Investments	0	125.5M	147.39M	239.48M	422.31M	465.94M	553.64M	689.58M	981.85M
Short-Term Investments	0	101.91M	122.22M	217.15M	397.99M	432.68M	515.06M	643.8M	470.43M
Total Current Assets+	9.76M	142.66M	164.94M	303.76M	585.1M	0	0	0	0
Cash & Equivalents	9.76M	10.78M	9.53M	33.12M	33.54M	50.28M	68.11M	51.55M	80.44M
Receivables	0	1000K	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	8.4M	31.91M	54.17M	0	-786.61M	-1.14B	-1.5B	-1.53B
Goodwill & Intangibles+	11.4M	744K	744K	744K	11.51M	9.5M	8.26M	12.31M	13.24M
Goodwill	0	0	0	0	0	0	0	3.75M	3.75M
Intangible Assets	11.4M	744K	744K	744K	11.51M	9.5M	8.26M	8.56M	9.49M
PP&E (Net)	920K	827K	947K	845K	739K	527K	603K	373K	429K
Other Assets	123.06M	-127.07M	-149.08M	-4.58M	-8.6M	-475.97M	-562.5M	-702.26M	-995.52M
Total Liabilities	16.97M	109.94M	139.96M	176.91M	365.38M	531.57M	921.7M	1.24B	1.53B
Total Debt+	16.97M	17.09M	19.08M	0	0	0	36.4M	52.6M	0
Net Debt	7.22M	6.31M	9.55M	-33.12M	-33.54M	-50.28M	-31.71M	1.05M	-80.44M
Long-Term Debt	16.97M	17.09M	19.08M	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	36.4M	52.6M	0
Total Current Liabilities+	0	11.57M	24.97M	1.12M	42.96M	0	0	0	0
Accounts Payable	0	11.57M	19.85M	24.94M	42.96M	58.74M	171.89M	224.12M	260.25M
Deferred Revenue	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	-11.58M	-19.85M	-24.93M	0	-58.74M	-208.29M	-283.97M	-260.25M
Deferred Taxes	0	0	0	1000K	1000K	1000K	0	0	0
Other Liabilities	0	0	0	0	0	-3.91M	0	0	0
Total Equity+	73.11M	78.41M	91.17M	218.56M	363.71M	394.17M	384.75M	471.25M	729.03M
Equity Growth %	-	0.07%	0.16%	1.4%	0.66%	0.08%	-0.02%	0.22%	0.55%
Shareholders Equity	73.11M	78.41M	91.17M	218.56M	363.71M	394.17M	384.75M	471.25M	729.03M
Minority Interest	0	0	0	0	0	0	0	0	0
Retained Earnings	3.59M	6.92M	275K	33.86M	39.96M	69.95M	87.71M	144.64M	262.22M
Common Stock	0	2K	2K	2K	3K	3K	3K	3K	3K
Accumulated OCI	1.02M	2.99M	-563K	4.69M	13.25M	5.31M	-36.52M	-23.99M	-26.84M
Return on Equity (ROE)	0.09%	0.05%	0.21%	0.07%	0.02%	0.12%	0.13%	0.19%	0.2%
Return on Assets (ROA)	0.05%	0.02%	0.09%	0.03%	0.01%	0.06%	0.05%	0.05%	0.06%
Equity / Assets	-	-	-	-	-	-	-	-	-
Debt / Equity	0.23x	0.22x	0.21x	-	-	-	0.09x	0.11x	-
Book Value per Share	3.23	3.47	4.03	10.01	14.21	15.10	14.92	18.61	27.80
Tangible BV per Share	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	15.82M	20.25M	22.81M	41.7M	53.55M	87.81M	169.58M	116.11M	261.16M
Operating CF Growth %	-	0.28%	0.13%	0.83%	0.28%	0.64%	0.93%	-0.32%	1.25%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-
Net Income	6.61M	3.78M	18.22M	10.62M	6.26M	45.85M	52.17M	79.2M	117.57M
Depreciation & Amortization	88K	160K	212K	216K	1.34M	3.54M	4.12M	4.5M	5.11M
Stock-Based Compensation	0	0	0	24.1M	2.17M	5.58M	11.62M	14.91M	16.68M
Deferred Taxes	-337K	1.13M	0	646K	1.09M	641K	-3.52M	-2.83M	2.11M
Other Non-Cash Items	581K	473K	3.49M	-3.09M	-274K	1.15M	9.37M	-2.95M	-5.51M
Working Capital Changes	8.88M	14.7M	884K	9.2M	42.97M	31.05M	95.82M	23.27M	125.2M
Cash from Investing+	-11.53M	-19.13M	-25.36M	-80.57M	-181.44M	-58.19M	-156.81M	-128.48M	-306.24M
Capital Expenditures	-898K	-68K	-332K	-2.93M	-4.07M	-18K	-313K	-15K	-243K
Acquisitions	4K	0	0	2.81M	-7.07M	-11K	-15K	-8.53M	0
Purchase of Investments	-40.1M	-54.21M	-136.46M	-270.44M	-341.95M	-216.57M	-392.63M	-234.72M	-607.1M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Other Investing	4K	-250K	250K	1.02M	1.42M	-3.34M	-6.57M	-5.79M	301.1M
Cash from Financing+	0	0	1.55M	62.29M	128.33M	-13.04M	5.02M	-3.94M	73.77M
Dividends Paid	0	0	0	-5.12M	0	0	0	0	0
Share Repurchases	0	0	0	0	0	-15.85M	-34.41M	-22.27M	0
Stock Issued	0	0	0	87.41M	125.55M	0	0	0	123.62M
Debt Issuance (Net)	0	0	1000K	-1000K	0	0	1000K	1000K	1000K
Other Financing	0	0	0	0	2.78M	2.81M	3.03M	2.13M	-112.97M
Net Change in Cash+	4.29M	1.12M	-1.01M	23.43M	437K	16.59M	17.79M	-16.31M	28.69M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0
Cash at Beginning	5.52M	9.81M	10.93M	9.92M	33.35M	33.79M	50.37M	68.16M	51.85M
Cash at End	9.81M	10.93M	9.92M	33.35M	33.79M	50.37M	68.16M	51.85M	80.54M
Free Cash Flow+	14.93M	20.18M	22.48M	38.77M	49.48M	82.96M	163.65M	109.35M	260.91M
FCF Growth %	-	0.35%	0.11%	0.73%	0.28%	0.68%	0.97%	-0.33%	1.39%
FCF Margin %	-	-	-	-	-	-	-	-	-
FCF per Share	0.66	0.89	0.99	1.78	1.93	3.18	6.34	4.32	9.95

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	85.3%	91.71%	75.04%	84.04%	96.31%	76.94%	79.35%	72.43%	72.7%
Medical Cost Ratio	57.69%	63.31%	47.28%	37.82%	76.07%	55.24%	57.92%	47.97%	51.35%
Return on Equity (ROE)	9.05%	4.99%	21.49%	6.86%	2.15%	12.1%	13.4%	18.5%	19.59%
Return on Assets (ROA)	4.56%	2.27%	8.69%	3.39%	1.11%	5.54%	4.67%	5.25%	5.92%
Equity / Assets	50.37%	41.63%	39.45%	55.27%	49.89%	42.58%	29.45%	27.59%	32.23%
Book Value / Share	3.23	3.47	4.03	10.01	14.21	15.1	14.92	18.61	27.8
Debt / Equity	0.23x	0.22x	0.21x	-	-	-	0.09x	0.11x	-
Revenue Growth	-	39.28%	22.71%	55.26%	48.69%	47.09%	32%	14.93%	47.33%

Frequently Asked Questions

Valuation & Price

Palomar Holdings, Inc. (PLMR) has a price-to-earnings (P/E) ratio of 29.1x. This suggests investors expect higher future growth.

Growth & Financials

Palomar Holdings, Inc. (PLMR) grew revenue by 47.3% over the past year. This is strong growth.

Yes, Palomar Holdings, Inc. (PLMR) is profitable, generating $175.9M in net income for fiscal year 2024 (21.2% net margin).

Dividend & Returns

Palomar Holdings, Inc. (PLMR) has a return on equity (ROE) of 19.6%. This is reasonable for most industries.

Industry Metrics

Palomar Holdings, Inc. (PLMR) has a combined ratio of 72.7%. A ratio below 100% indicates underwriting profitability.